维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="Muirhead N"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Evidence-based recommen-dation8 for the clirIical use of recombinant human erythrooietin显示文摘	Muirhead N Bergman J Burgess E	1995	Am J kidney Dis1995，26，：	1
2	Supramaximal dose of candesartan in proteinurie renal disease 显示文摘	Burgess E Muirhead N de Cotret P R	2009	J Am Soc Nephrol2009，20，4：	1
3	A disease - specific questionnaire for assessing quality of life in patients on hemodi alysis显示文摘	Laupaeis A Muirhead N Keown P	1992	Nephron1992，60，3：	1
4	Patient survival following renal transplant failure in Canada显示文摘	KNOLL G MUIRHEAD N TRPESKI L	2005	Am J Transplant2005，5，7：	1
5	Patient quality of life on quotidian dialysis显示文摘	HEIDENHEIM A P MUIRHEAD N MOIST L	2003	Am J Kindey Dis2003，42，1：	1
6	Supramaximal dose of candesartan in proteinuric renal disease显示文摘	Burgess E Muirhead N Rene de Cotret P	2009	J Am Soc Nephrol2009，20，4：	1
7	Management of idiopathic membranous nephropathy:evidence-based recommendation显示文摘	Muirhead N	1999	Kidney Iht1999，70，：	1
8	Patient quality of life on quotidian hemodialysis显示文摘	Heidenheim AP Muirhead N Moist L		Am J Kidney Dis0，42，：	1
9	Predictors of erythropoietin responsiveness in chronic hemodialysis patients显示文摘	Tonelli M Blake PG Muirhead N	2004	Asatio J2004，47，1：	1
10	Evidence-based recommendations for the clinical use of recombinant human erythropoietin显示文摘	Muirhead N Bargman J Burgess E	1995	Am J Kidney Dis1995，26，1：	1
11	Man agement of anemia with quotidian hemodialysis显示文摘	Rao M Muirhead N Klarenbach S	2003	Am J Kidney Dis2003，42，1：	1
12	Management of idiopathic membranous nephropathy:evidence-based recommendations显示文摘	Muirhead N	1999	Kidney Int1999，70，：	1
13	Proteinuria and reduced kidney function in living kidney donors:a systematic review,meta-analysis,and meta-regression显示文摘	Grag A X Muirhead N Knoll G	2006	Kidney Int2006，70，10：	1
14	Management of idiopathic membranous ne- phropathy: evidence-based recommendations显示文摘	Muirhead N	1999	Kidney lnt Suppl1999，70，：	1
15	Erythropoietin for anemia in haemodialysis patients:results of a maintenance study (the Canadian Erythropoietin Study Group)显示文摘	Muirhead N Laupacis A Wong C	1992	Nephrol Dial Transplant1992，7，8：	1
16	Evidence-based recommendations for the clinical use of recombinant human erythropoietin 显示文摘	Muirhead N bergman J Burgess E	1995	Am J Kidney Dis1995，26，：	1
17	Predictors of erythropoietin responsiveness in chronic hemodialysis patients显示文摘	Blake PG Muirhead N	2001	ASATIO J2001，47，1：	1
18	A disease specific questionnaire for assessing quality of life in patients on hemodi- alysis显示文摘	Laupacis A Muirhead N Keown P	1992	Nephrol1992，60，：	1
19	Management of idiopathic membranous nephropathy: evidence-based recommendations 显示文摘	Muirhead N	1999	Kidney Int Suppl1999，70，：	1
20	In reply to A perspective from the Baltics regarding the Canadian Society of Nephrology commentary on the KDIGO Glomerulonephritis Guideline显示文摘	Muirhead N	2014	Am J Kidney Dis2014，64，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示